Pitfalls in the diagnostic evaluation of hyperprolactinemia
L Vilar, CF Vilar, R Lyra, MC Freitas - Neuroendocrinology, 2019 - karger.com
An appropriate diagnostic evaluation is essential for the most appropriate treatment to be
performed. Currently, macroprolactinemia is the third most frequent cause of …
performed. Currently, macroprolactinemia is the third most frequent cause of …
Controversial issues in the management of hyperprolactinemia and prolactinomas–An overview by the Neuroendocrinology Department of the Brazilian Society of …
Prolactinomas are the most common pituitary adenomas (approximately 40% of cases), and
they represent an important cause of hypogonadism and infertility in both sexes. The …
they represent an important cause of hypogonadism and infertility in both sexes. The …
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas
In June 2005, an ad hoc Expert Committee formed by the Pituitary Society convened during
the 9th International Pituitary Congress in San Diego, California. Members of this committee …
the 9th International Pituitary Congress in San Diego, California. Members of this committee …
Hyperprolactinemia and prolactinomas
Hyperprolactinemia is one of the most frequently diagnosed clinical disorders in routine
endocrine practice. Any process interfering with dopamine synthesis, its transport to the …
endocrine practice. Any process interfering with dopamine synthesis, its transport to the …
PCOS and Hyperprolactinemia: what do we know in 2019?
Polycystic ovary syndrome (PCOS) and hyperprolactinemia (HPRL) are the two most
common etiologies of anovulation in women. Since the 1950s, some authors think that there …
common etiologies of anovulation in women. Since the 1950s, some authors think that there …
Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory …
AM Suliman, TP Smith, J Gibney… - Clinical …, 2003 - academic.oup.com
Background: Macroprolactin (big big prolactin) has reduced bioactivity and is measured by
immunoassays for prolactin when it accumulates in the plasma of some individuals. We …
immunoassays for prolactin when it accumulates in the plasma of some individuals. We …
Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients
L Vilar, MC Freitas, LA Naves, LA Casulari… - Journal of …, 2008 - Springer
Objective: The aim of the study was to evaluate clinical and laboratorial features of 1234
patients with different etiologies of hyperprolactinemia, as well as the response of 388 …
patients with different etiologies of hyperprolactinemia, as well as the response of 388 …
Determination of prolactin: the macroprolactin problem
M Fahie-Wilson, TP Smith - … Practice & Research Clinical Endocrinology & …, 2013 - Elsevier
Serum prolactin is frequently measured when investigating patients with reproductive
disorders and elevated concentrations are found in up to 17% of such cases. Clinical …
disorders and elevated concentrations are found in up to 17% of such cases. Clinical …
[PDF][PDF] Clinical relevance of macroprolactin.
J Gibney, TP Smith, TJ McKenna - Clinical Endocrinology, 2005 - saegre.org.ar
The anterior pituitary hormone PRL was identified in animal species as early as 19331 but
only purified in humans in 1972. 2 Since then, the clinical syndrome of hyperprolactinaemia …
only purified in humans in 1972. 2 Since then, the clinical syndrome of hyperprolactinaemia …
The impact on clinical practice of routine screening for macroprolactin
J Gibney, TP Smith, TJ McKenna - The Journal of Clinical …, 2005 - academic.oup.com
Background: Macroprolactin has reduced bioactivity in vivo and accumulates in the sera of
some subjects, resulting in pseudo-hyperprolactinemia and consequent misdiagnosis …
some subjects, resulting in pseudo-hyperprolactinemia and consequent misdiagnosis …